SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+1.62%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$656M
AUM Growth
+$656M
(-4.6%)
Cap. Flow
-$48.6M
Cap. Flow
% of AUM
-7.41%
Top 10 Holdings %
Top 10 Hldgs %
63.24%
Holding
31
New
5
Increased
8
Reduced
14
Closed
3
Top Buys
| 1 |
AstraZeneca
AZN
|
$25.1M |
| 2 |
Eli Lilly
LLY
|
$20.9M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$12.2M |
| 4 |
NUVA
NuVasive, Inc.
NUVA
|
$10.1M |
| 5 |
Biogen
BIIB
|
$8.2M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$27.4M |
| 2 |
Masimo
MASI
|
$18.4M |
| 3 |
Gilead Sciences
GILD
|
$17.2M |
| 4 |
Abbott
ABT
|
$14.2M |
| 5 |
LPNT
LifePoint Health, Inc.
LPNT
|
$10.1M |
Sector Composition
| 1 | Healthcare | 98.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
GSK
GSK
$79.9B
| $5.55M | 0.85% | +136,655 | New | +$5.55M |
|
27
Owens & Minor
OMI
$378M
| $5.14M | 0.78% | 175,874 | – | – |
|
|
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
| $1.51M | 0.23% | +39,173 | New | +$1.51M |
|
|
29
Masimo
MASI
$7.59B
| – | – | -201,418 | Closed | -$18.4M |
|
|
ALXN
30
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – | -40,300 | Closed | -$4.9M |
|
|
LPNT
31
DELISTED
LifePoint Health, Inc.
LPNT
| – | – | -149,714 | Closed | -$10.1M |
|